ACELYRIN, Inc. IPO Research Information

ACELYRIN, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on ACELYRIN, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
ACELYRIN, Inc.	SLRN - NASDAQ	30 million	$18.00	$23.00	$16.00-$18.00	5/5/2023
Underwriter(s): Morgan Stanley, Jefferies, TD Cowen, Piper Sandler
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2023-04-13 Terms Added 2023-05-01 Amended Prospectus 2023-05-03

ACELYRIN, Inc. Quote & Chart - Click for current quote - SLRN

About ACELYRIN, Inc. (adapted from ACELYRIN, Inc. prospectus):
ACELYRIN is a late-stage clinical biopharma company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "SLRN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.